cbdMD Schedules Q1 2026 Earnings Call Amid CBD Market Shifts

  • cbdMD (NYSE American: YCBD) will host an earnings call on February 17, 2026, at 4:20 p.m. ET to discuss Q1 2026 results.
  • The call will cover financial performance and business progress for the quarter ending December 31, 2025.
  • cbdMD operates multiple brands including CBD products, pet products, functional mushrooms, and THC-infused beverages.
  • Webcast replay available through February 17, 2027.

cbdMD's earnings call comes at a time when the CBD market is experiencing both growth and regulatory scrutiny. The company's diversified product lineup, including THC-infused beverages and pet products, positions it uniquely in a crowded space. Investors will be watching for signs of sustained revenue growth and operational efficiency amid shifting market dynamics.

Market Positioning
How cbdMD's diversified product portfolio will perform in a competitive CBD market.
Regulatory Compliance
Whether the company can sustain growth amid evolving cannabis regulations.
Financial Health
The pace at which cbdMD can improve profitability and revenue growth.